Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)

China flag China · Delayed Price · Currency is CNY
10.30
+0.27 (2.69%)
Feb 4, 2026, 11:44 AM CST
68.85%
Market Cap5.65B +89.1%
Revenue (ttm)1.13B +16.1%
Net Income33.43M
EPS0.07
Shares Out562.87M
PE Ratio140.33
Forward PEn/a
Dividend0.05 (0.50%)
Ex-Dividend Daten/a
Volume57,851,334
Average Volume37,867,707
Open9.50
Previous Close10.03
Day's Range9.50 - 10.68
52-Week Range5.42 - 11.98
Beta0.33
RSI67.91
Earnings DateApr 22, 2026

About SHE:300016

Beijing Beilu Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products in China. The company provides contrast agents, such as gadopentetate meglumine injection, gadobutrol injection, and gadobenate meglumine injection for MRI contrast; and iohexol injection, iopamidol injection, and iodixanol injection for CT contrast, as well as glimepiride and repaglinide tablets and jiuwei zhenxin granules. It also offers gadolinium-based agents, including gadopentetate dimeglumine and gadobutrol, as wel... [Read more]

Sector Healthcare
Founded 1992
Employees 1,173
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300016
Full Company Profile

Financial Performance

Financial Statements